Anja Wegner

Dr. Anja Wegner

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2012 in Nature Medicine
Verified
Journal Article
Closed access
JBJohannes vom Berg
Johannes vom Berg
SPStefan Prokop
Stefan Prokop
KMKelly R Miller
Kelly R Miller
JOJuliane Obst
Juliane Obst
RKRoland E Kälin
Roland E Kälin
FHFrank L Heppner
Frank L Heppner

31 January 2012 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
JVJonathan Vinet
Jonathan Vinet
HWHilmar Rj van Weering
Hilmar Rj van Weering
AHAnnette Heinrich
Annette Heinrich
RKRoland E Kälin
Roland E Kälin
AWAnja Wegner
Anja Wegner
KBKnut Biber
Knut Biber
Background: Most of the known functions of microglia, including neurotoxic and neuroprotective properties, are attributed to morphologically-activated microglia. Resting, ramified microglia are suggested to primarily monitor their environment including synapses. Here, we show an active protective role of ramified microglia in excitotoxicity-induced neurodegeneration. Methods: Mouse organotypic hippocampal slice cultures were treated with N-methyl-D-aspartic acid (NMDA) to induce excitotoxic neuronal cell death. This procedure was performed in slices containing resting microglia or slices that were chemically or genetically depleted of their endogenous microglia. Results: Treatment of mouse organotypic hippocampal slice cultures with 10-50 μM N-methyl-D-aspartic acid (NMDA) induced region-specific excitotoxic neuronal cell death with CA1 neurons being most vulnerable, whereas CA3 and DG neurons were affected less. Ablation of ramified microglia severely enhanced NMDA-induced neuronal cell death in the CA3 and DG region rendering them almost as sensitive as CA1 neurons. Replenishment of microglia-free slices with microglia restored the original resistance of CA3 and DG neurons towards NMDA. Conclusions: Our data strongly suggest that ramified microglia not only screen their microenvironment but additionally protect hippocampal neurons under pathological conditions. Morphological activation of ramified microglia is thus not required to influence neuronal survival.

12 October 2015 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SPStefan Prokop
Stefan Prokop
KMKelly R. Miller
Kelly R. Miller
NDNatalia Drost
Natalia Drost
SHSusann Handrick
Susann Handrick
VMVidhu Mathur
Vidhu Mathur
FHFrank L. Heppner
Frank L. Heppner
Although central nervous system–resident microglia are believed to be ineffective at phagocytosing and clearing amyloid-β (Aβ), a major pathological hallmark of Alzheimer’s disease (AD), it has been suggested that peripheral myeloid cells constitute a heterogeneous cell population with greater Aβ-clearing capabilities. Here, we demonstrate that the conditional ablation of resident microglia in CD11b-HSVTK (TK) mice is followed by a rapid repopulation of the brain by peripherally derived myeloid cells. We used this system to directly assess the ability of peripheral macrophages to reduce Aβ plaque pathology and therefore depleted and replaced the pool of resident microglia with peripherally derived myeloid cells in Aβ-carrying APPPS1 mice crossed to TK mice (APPPS1;TK). Despite a nearly complete exchange of resident microglia with peripheral myeloid cells, there was no significant change in Aβ burden or APP processing in APPPS1;TK mice. Importantly, however, newly recruited peripheral myeloid cells failed to cluster around Aβ deposits. Even additional anti-Aβ antibody treatment aimed at engaging myeloid cells with amyloid plaques neither directed peripherally derived myeloid cells to amyloid plaques nor altered Aβ burden. These data demonstrate that mere recruitment of peripheral myeloid cells to the brain is insufficient in substantially clearing Aβ burden and suggest that specific additional triggers appear to be required to exploit the full potential of myeloid cell–based therapies for AD.

28 March 2023 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SCStephan Culemann
Stephan Culemann
KKKatharina Knab
Katharina Knab
MEMaximilien Euler
Maximilien Euler
AWAnja Wegner
Anja Wegner
HGHilal Garibagaoglu
Hilal Garibagaoglu
GKGerhard Krönke
Gerhard Krönke
Clodronate liposomes (Clo-Lip) have been widely used to deplete mononuclear phagocytes (MoPh) to study the function of these cells in vivo. Here, we revisited the effects of Clo-Lip together with genetic models of MoPh deficiency, revealing that Clo-Lip exert their anti-inflammatory effects independent of MoPh. Notably, not only MoPh but also polymorphonuclear neutrophils (PMN) ingested Clo-Lip in vivo, which resulted in their functional arrest. Adoptive transfer of PMN, but not of MoPh, reversed the anti-inflammatory effects of Clo-Lip treatment, indicating that stunning of PMN rather than depletion of MoPh accounts for the anti-inflammatory effects of Clo-Lip in vivo. Our data highlight the need for a critical revision of the current literature on the role of MoPh in inflammation.

2 March 2017 in Immunology
Verified
Journal Article
Closed access
PDF file
AWAnja Wegner
Anja Wegner
JVJohan Verhagen
Johan Verhagen
DWDavid Wraith
David Wraith